1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.

Slides:



Advertisements
Similar presentations
Clinical Expertise Database Sue Watson Head of MedTech Services Health Enterprise East.
Advertisements

NIHR Delivering Better Health Through Training Researchers 19 September 2011 Dr David Cox Deputy Director – Research Faculty.
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Steps 2 Success (NI) Building Partnerships and Working Together Seminar 1 - Creating value through partnerships Strictly Private & Confidential David Knowles,
Towards a New R&D Strategy A blueprint for R&D in Health and Social Care Noreen Caine Deputy Director of R&D, DH NHS R&D Forum Annual Conference May 2005.
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
TBD-UK: The UK response in the discovery and development of new TB drugs. Dr Geoff Coxon Deputy Leader & Director of Medicinal Chemistry, TBD-UK APPG-TB.
“Best Research for Best Health” Andrew Riley Managing Director.
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
Global Context As the rich world gets older and sicker and the poor world gets wealthier and fatter, the demand for medical innovation is exploding. Clever.
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
Driving Innovation Concept to Commercialisation A strategy for business innovation, Zahid Latif Head of Healthcare Mark Glover 12 th January.
Janet Darbyshire (25 June 07) UK Clinical Research Network (UKCRN) Identifying research priorities in the UK Clinical Research Network.
Copyright © 2012 Quintiles An Industry View of Working in NHS Wales Paula Jefferies – Site Relationship Manager Quintiles 11 th December 2012.
Oakland University William Beaumont School of Medicine An Opportunity of a Lifetime.
Irish Health Research: Collaboration and Partnership HSE Regional Library & Information Health Research Seminar Dr. Steevens’ Hospital 11th February 2011.
Discovery of new medicines through new models of collaboration Simon Ward Professor of Medicinal Chemistry & Director of Translational Drug Discovery Group.
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) A single system for processing and reviewing applications.
The NIH Roadmap for Medical Research
1 Presentation title - edit in the Master slide 1 Current Investment Opportunities Professor Rory Shaw, Medical Director, Healthcare UK, UKTI.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.
Working across sectors Building collaborative eco-systems Lars Sundstrom SARTRE.
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
NIHR Delivering Better Health 26 November 2013, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
Unlock Your Global Business Potential: Addressing the Dementia Challenge.
Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.
Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)
Alzheimer’s disease Platforms for translational research.
100k Genomes Project In December 2012 the Prime Minister announced a programme of Whole Genome Sequencing as part of the UK Government’s Life Sciences.
Barriers to innovation – and solutions The Collaboration Conundrum Colette Goldrick, Director ABPI Northern Ireland.
How can we work together? Partnering with Industry: An Investigator’s Perspective Robert L. Coleman, MD M. D. Anderson Cancer Center.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
Training the future leaders of the biomedical engineering field – world-class research, experience of clinical translation and exposure to making inventions.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
Presentation/Phenotype
Robert H. Wiltrout Director, CCR Director’s Address.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
MRC Technology an independent life science medical research charity Biotech & Money 2016 Mr Andrew Mercieca, Director of Finance
Challenges facing biomedicine Data handling and mining Redefining disease Therapeutics.
NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.
Realising MRC’s Vision in Health and Bioinformatics MRC Open Council Meeting July 2014 Janet Valentine Head of Population Health and Informatics.
Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.
Brokering Beneficial Collaborations Opportunities for working in partnership Lucy Chatwin - Head of Programmes West Midlands AHSN
The future of the NIHR NIHR: 10 years of delivering health and care research for the nation QEII Centre, London Wednesday 18 May 2016 Professor Chris Whitty.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
Engaging and Supporting Surgical Research: Clinical Research Networks
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
The Industrial Strategy Challenge Fund & the Focus on Life Sciences
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
John Adler Chief Executive, Leicester’s Hospitals
Title Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Clinical and Translational Science Awards Program
Title Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Experimental Medicine Challenge Grants Round 3
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
UKCRC Public Health Research Centres of Excellence
Clinical research in Southampton is a partnership between University Hospital Southampton (UHS) NHS Foundation Trust and the University of Southampton.
Title Southampton Clinical Research Facility Southampton Biomedical Research Centre Clinical research in Southampton is a partnership between University.
Clinical research in Southampton is a partnership between University Hospital Southampton NHS Foundation Trust and the University of Southampton, combining.
Presentation transcript:

1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product launch Regulatory submission and approval Late stage clinical trials Experimental medicine

2 The UK Opportunity: Globally Competitive The UK offers your company access to: UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Translational research expertise with world – renowned KOLs Unrivalled data and well-characterised patient cohorts Leading translational research facilities co- located within the hospital setting

3 The UK research ecosystem supports innovation flow from discovery science through to evidence generation and uptake Pre-clinical research Early-phase clinical research (phase 1 to 2) Later-phase clinical research (phase 3) Translational Research Centres Translating biological discovery into the clinical setting Translational Research Centres including NIHR Biomedical Research Centres and Units, Translational Research Partnerships (TRPs) and Collaborations (TRCs) Clinical Research Networks Embedded in the NHS supporting the delivery of multicentre clinical studies UK Clinical Research Facilities and Experimental Cancer Medicine Centres Expertly delivering early stage patient studies Medical Research Council and medical research charities. Research funding focused on the mechanisms of health and disease UNLOCK YOUR GLOBAL BUSINESS POTENTIAL UK Health data In the UK, your business will have access to unrivalled, clinically-coded health data and bio- repositories

4 The UK has the visionary science, centres of academic and clinical excellence, key opinion leaders, experienced partners, and the tools to help your business The UK is home to world-class discovery science.. Text com es here Text com es Identify patient cohorts Develop sensing and diagnostic technologies Discover and validate biomarkers Deliver engineering and informatics solutions Understand disease biology Develop novel targets for drug discovery The UK can help your business.. UNLOCK YOUR GLOBAL BUSINESS POTENTIAL The Medical Research Council The Wellcome Trust Cancer Research UK and Cancer Research Technology

5 The UK is home to world-class translational research infrastructure that works in partnership with industry..with translational research expertise and infrastructure to take your innovation from discovery to the clinic NIHR Translational Research Partnerships NIHR Biomedical Research Centres and Units Scotland Leading academic centres of excellence in drug discovery and experimental medicine Wales & NI provide industry with leading experimental medicine centres within leading hospital partnerships. UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Text com es here Access to patient samples and biobanks Access state of the art technology platforms Access well characterised cohorts of patients Conduct fast and efficient experimental research Conduct biomarker-led approaches to patient stratification Develop and test new therapeutic targets The UK can help your business..

6 UK Clinical Research Faculties support inpatient and outpatient clinical research studies across a wide range of disciplines, led by investigators in both adult and paediatric specialities Expert clinical research facilities support inpatient and outpatient clinical research Text com es here Quickly identify the right centres of excellence for a particular study Conduct cost- effective and smarter clinical research Design and deliver complex clinical studies Connect to world-leading principal investigators Speed up the flow of innovation from bench to bedside Connect to expert research nurses experienced at running early stage trials UNLOCK YOUR GLOBAL BUSINESS POTENTIAL UK Clinical Research Facilities for Experimental Medicine UK Experimental Cancer Medicine Centres The UK can help your business..

7 Clinical Research Networks provide infrastructure to support clinical research in the NHS, giving patients access to high quality research studies and supporting the Life-Sciences Industry to develop potential new treatments Experimental research can be rapidly and efficiently translated to extensive late stage clinical research networks across the UK NIHR Clinical Research Network in England Scotland has clinical research networks in Diabetes, Dementia and Cancer. Through the Northern Ireland Clinical Research Network and Health Research Wales, your business can be connected to expertise and networks to conduct late stage clinical research in these regions Text com es here Speed up costing and contracting at sites Trouble shoot support from inside the NHS to keep study on track Identify the right sites drawing on more than 1000 primed investigators Rapidly set up multi-site studies Get advice on compatibility of protocols with current UK clinical practice Access GCP trained nurses to support patient recruitment The UK can help your business.. UNLOCK YOUR GLOBAL BUSINESS POTENTIAL

8 In the UK, your business will have access to stable unrivalled, clinically-coded health data and bio- repositories. …supported by a single health system with unrivalled, clinically- coded health data to drive delivery of clinical research More than 60 million people are served by a National Health System Example data resources: –UK Biobank –The Scottish Health Informatics Programme (SHIP) –NIHR BioResource –Clinical Practice Research Datalink (CPRD) “We have had a very productive relationship with the Cambridge Bioresource (CBR) over the last two to three years where collaboration has resulted in provision of genetic resource, conduct of clinical and translational trials, and publication of both clinical and immuno-inflammatory mechanistic study results related to pharmacogenetic interactions. The initial interactions between us (industry) and CBR have been very successful and this is a collaboration we are keen to maintain and develop.” Simon McHugh, Director of Scientific Operations at GlaxoSmithKline UNLOCK YOUR GLOBAL BUSINESS POTENTIAL